Cover Story | ACC.18: See It, Hear It, Live It

Groundbreaking cardiovascular science: check. World-class faculty: check. The stage is set for ACC’s premier education event of the year – ACC.18 in Orlando, FL.

More than 18,000 cardiovascular professionals are expected to attend this year’s meeting, which has been carefully crafted to showcase the latest and greatest in cardiovascular science, expand clinical skills, and spark innovation and discussion. With more than 300 education sessions featuring 1,605 expert faculty, 2,700 accepted abstracts presented in oral and poster sessions by 2,100 experts, and 37 Late-Breaking Clinical Trials and Featured Clinical Research presentations, ACC.18 is quite simply the meeting to see, hear and live everything cardiology has to offer.

Nanette Wenger to Headline ACC’s Opening Showcase Session

Cardiology Magazine Image

ACC President Mary Norine Walsh, MD, FACC, will open ACC.18 at Saturday’s Opening Showcase Session, where she will deliver her presidential address. Nanette Kass Wenger, MD, MACC, a pioneer in cardiovascular medicine, will set the pace with her 2018 Simon Dack Keynote. Once a student of Dr. Dack, Wenger’s address is titled “Understanding the Journey: The Past, Present and Future of CVD in Women.”

“Dr. Wenger has been a leader in cardiovascular medicine for decades and I’m very pleased she’s being recognized for her work through this prestigious lecture,” says Walsh.

The ACC.18 Opening Showcase Session and the Joint ACC/JACC Late-Breaking Clinical Trials Session will be held from 8:00 – 10:00 a.m. Saturday in Hall C (Main Tent).

“As we shaped this meeting, our focus has been interactivity and the attendee experience,” says ACC.18 Chair Jeffrey T. Kuvin, MD, FACC. “Attendees are the key ingredient in this recipe, leading us to schedule more time for audience participation so they are engaged learners – and even teachers.”

According to Kuvin, active engagement is built into every aspect of the meeting with the ultimate goal to allow members to learn from each other and also easily take what they’ve learned back to their practices, hospitals and patients the next day.

Sessions and educational exhibits are designed specifically to encourage thought-provoking panel discussions and lively debates. New this year, member volunteers representing each ACC.18 Learning Pathway will also be live Tweeting from key session pathways as a means of broadening discussions even further.

Interdisciplinary learning is also a key focus of ACC.18, with sessions, events and resources for every member of the cardiovascular care team.

The Lounge and Learn Pavilion will continue to serve as an important hub for such interdisciplinary activities, with its Personal Life Skills Center and a Simulation Lab for self-paced learning. New this year, the Heart 2 Heart Stage will feature short, casual 30-minute sessions on timely topics ranging from “MACRAnyms” to social media to prior authorization. The first presentation is “How to Navigate ACC.18: An Inside Look at This Year’s Program,” at 10:15 a.m. on Saturday.

“The Heart 2 Heart Stage is intended to provide knowledge in a less formal way and involve the audience,” says Andrew M. Kates, MD, FACC, vice chair of ACC.18. “It will focus on topics that may not be in the headlines, but they affect clinicians and practice.”

The Engage@ACC.18 Studio is another innovative and interactive theater with a 180-degree stage designed for audience participation. Among the many novel community-centered events taking place: FIT Jeopardy, Cardiology Contest, Family Feud, Heart Teams in Action and Quiz Bowl.

Special “intensives” focused on hot topics also return for ACC.18, but with formatting changes based on attendee feedback. This year’s focused, half-day sessions will provide closer looks at emerging technologies and the future of cardiovascular practice; adult congenital heart disease for the general cardiologist; and shared decision making for the clinician. And each includes a field trip! ACC Section Highlights are another unique learning opportunity for attendees at ACC.18. Each of the eight sessions will be held on Monday afternoon and moderated by leaders from the specific section. “We designed this session to give learners the chance to discuss and put into context the new information and science from the meeting, so they can immediately return to work and put it into action,” says Kates.

Late-breaking science is another hallmark of ACC’s Annual Scientific Session and the science presented at ACC.18 will not disappoint. Presentations on the much-anticipated ODYSSEY and VEST trials will kick off the Late-Breaking Clinical Trial sessions on Monday. Kates notes that attendees should be prepared for more interactivity and engagement at these sessions, as well as the three Intensive sessions and the expanded moderated poster presentations, in 2018.

“Providing meaningful information in a variety of formats for every type of learner has been a cornerstone of our design,” says Kates.

For the second year dual Continuing Medical Education (CME) and Maintenance of Certification (MOC) credit is available through some 300 sessions, allowing participants to easily meet American Board of Internal Medicine MOC requirements. Many sessions also provide continuing nursing education (CNE) and/or continuing pharmacy education (CPE) credit. International attendees can obtain external continuing medical education (ECME) credit. Claiming the credit is automated through the same app used to navigate ACC.18.

The ACC.18 Expo extends the learning opportunities. “The exposition is a great venue for interactivity, continued learning and interaction with our pharmaceutical and industry partners,” Kuvin says. “It’s an important and rich environment.” With nearly 300 exhibitors, Expo is the largest gathering of innovative cardiovascular products and services under one roof. It’s also the site of a number of Learning Destinations presentations as well as the Health IT Pavilion, Interventional Pavilion, and Patient Engagement Pavilion. The new Future Hub will highlight some of the up-and-coming technologies in the field and will be the site of the first-ever ACC.18 Innovation Challenge, in partnership with angelMD, where entrepreneurs and innovators will pitch their ideas for products and services in digital health and medical devices.

“The ACC Annual Scientific Session continues to be the place to learn the latest science and integrate key information into your practice,” says Kuvin. “It’s a time to connect with the science and to connect with the global cardiovascular community.”

ACC.18 Keynotes

Cardiology Magazine Image

Simon Dack Keynote
Nanette Kass Wenger, MD, MACC
Understanding the Journey: The Past, Present, and Future of CVD in Women
Saturday, March 10, 8:00 – 10:00 a.m.

Cardiology Magazine Image

Louis F. Bishop Keynote
Bernhard Meier, MD, FACC
40 Years of PCI and 15 Years of TAVR
Saturday, March 10, 12:15 – 1:45 p.m.

Cardiology Magazine Image

James T. Dove Keynote
John E. Brush, MD, FACC
Is the Thinking Cardiologist Obsolete?
Quality Outcomes Through Better Reasoning
Saturday, March 10, 2:00 – 3:30 p.m.

Cardiology Magazine Image

Douglas P. Zipes Young Scientist Awardee Presentation
Salim Hayek, MD
Kidney Disease and The Heart: Is suPAR the Missing Link?
Sunday, March 11, 10:45 a.m. – 12:15 p.m.

Cardiology Magazine Image

Maseri-Florio International Keynote
Alfred A. Bove, MD, PhD, MACC
From Regulation to Inflammation: The Evolving Understanding of Coronary Artery Disease
Sunday, March 11, 2:00 – 3:30 p.m.

Cardiology Magazine Image

Dan G. McNamara Keynote
John P. Cheatham, MD, FACC
Pediatric Interventional Cardiology: How Far We’ve Come and How Far We Have Yet to Go
Monday, March 12, 10:45 a.m. – 12:15 p.m.

Cardiology Magazine Image

Eugene Braunwald Keynote
John J. V. McMurray, MD, FACC
Heart Failure and Diabetes: Fighting the Battle on Two Fronts
Monday, March 12, 12:30 – 1:45 p.m.

Distinguished Awardees

Convocation Will Recognize New Class of FACCs and AACCs

Cardiology Magazine Image

After three days of the latest in cardiovascular research, interactive sessions and networking, ACC.18 will close with the time-honored tradition of Convocation. Presided over by the outgoing ACC president, the 67th Annual Convocation Ceremony will usher in the newest class of ACC Fellows and Associates, recognize award winners and welcome new ACC leaders. Convocation will take place on March 12, at 6:30 p.m., followed by the President’s, New Fellows’ and Associates Reception.

Late-Breaking Clinical Trial Sessions

Late-Breaking Clinical Trials (LBCTs) are a hallmark of ACC’s Annual Scientific Session – providing unique opportunities to hear first-hand from lead investigators about the latest practice-changing research. ACC.18 will feature five LBCT sessions. ODYSSEY and VEST will kick it all off immediately following the Opening Showcase Session on Saturday. Don’t miss the 17 Featured Clinical Research presentations in three sessions; find them with your ACC.18 app. Make time for the two Deep Dive sessions to gain more insight from the key clinical trials presented at ACC.18 and find out what it all means for you and your patients.

Saturday March 10

ACC.18 Opening Showcase and the Joint ACC/JACC Late-Breaking Clinical Trials
Session 401
9:00 – 10:00 a.m.

  • ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the ODYSSEY Outcomes Trial
  • VEST: Efficacy of a Wearable Cardioverter-Defibrillator after Myocardial Infarction: Results of the Vest Prevention of Early Sudden Death Trial

Sunday March 11

Joint ACC/Journal of the American Medical Association Late-Breaking Clinical Trials
Session 404
8:00 – 9:15 a.m.

  • PHARMCLO: A Prospective, Randomised, Multicentre Study of A Pharmacogenomic Approach To The Selection Of Antiplatelet Therapy In Acute Coronary Syndromes
  • ARTEMIS: Impact of Patient Copayment Reduction on P2Y12 Inhibitor Persistence and Clinical Outcomes after Myocardial Infarction: The Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS) Randomized Trial
  • TREAT: A Phase III, Randomized, International, Multicenter, Open label, with Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome with ST Elevation Treated with Thrombolysis
  • MANAGE: The Effect of Dabigatran in Patients Suffering Myocardial Injury After Noncardiac Surgery
  • SECURE-PCI: Loading Doses of Atorvastatin versus Placebo in Patients with Acute Coronary Syndromes and Planned Revascularization

Late-Breaking Clinical Trials
Session 405
10:45 – 11:45 a.m.

  • MOMENTUM 3: Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) - Long Term Outcomes
  • INDIE-HFpEF: Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure with Preserved Ejection Fraction: The INDIE Trial
  • Ceccy: Carvedilol for Prevention of Chemotherapy-Induced Cardiotoxicity - Results of the Prospective, Randomized, Double Blind, Placebo-Controlled Ceccy Trial
  • Lisinopril or Carvedilol for Prevention of Trastuzumab Induced Cardiotoxicity

Deep Dive I
Session 406
12:30 – 1:45 p.m.

Monday March 12

Joint ACC/New England Journal of Medicine Late-Breaking Clinical Trials
Session 408
8:00 – 9:15 a.m.

  • CARES: Primary Results of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Comorbidities
  • CANTOS: Anti-Inflammatory Therapy with Canakinumab and Incident Type 2 Diabetes: A Pre-Specified Key Secondary Endpoint of the CANTOS Trial
  • Blood Pressure Reduction in Black Barbershops
  • TRIUMPH: A Pragmatic Trial of a Low-dose Triple-Combination Blood Pressure Lowering Pill for Initial Treatment of Hypertension
  • POISE: 1-Year Outcomes of Perioperative Beta-blockade in Patients Undergoing Noncardiac Surgery

Late-Breaking Clinical Trials: Interventional Cardiology
Session 409
10:45 – 11:45 a.m.

  • STOP-PAD: A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization to Enhance Wound Healing
  • Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients with High-Risk Patent Foramen Ovale
  • SMART-DATE: Safety of 6-Month Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
  • ANNEXA-4: Interim Report on the ANNEXA-4 Study: Andexanet For Reversal of Anticoagulation in Factor Xa - Associated Acute Major Bleeding

Deep Dive II
Session 411
12:30 – 1:45 p.m.

Download Before You Go! The ACC.18 App helps you See It, Hear It, Live It! Plan your ACC.18 experience today.

Cardiology Magazine Image

Make the most of ACC.18 with instant access to sessions, abstracts, exhibitors, maps and more. Browse sessions by day, pathway or practice focus and build a personalized itinerary. Seamlessly claim credit or get a certificate of participation, access live streaming sessions, download session slides (24 hours after each presentation), get the latest news via ACC’s twitter feed, and more. Search “ACC.18” in the app store or browse the online meeting planner at ACCScientificSession.org.

ACC.18: Something for Everyone

Whether a practicing cardiologist, Early Career Professional, Fellow in Training (FIT) or a member of the Cardiovascular (CV) Team, ACC.18 provides something for everyone. Hands-on training and the opportunity for meaningful interaction with global thought leaders while building community and gaining knowledge to improve cardiovascular care and improve heart health are guiding principles of ACC.18.

Don’t miss the All Sections Reception taking place on Sunday, March 11 at 6:30 p.m. at the Hyatt Regency Orlando.

FIT and Early Career Professional Members

Cardiology Magazine Image

Today’s Fellows in Training (FIT) and Early Career professionals will begin their careers in a changing, complex health care scenario that includes multiple specialty choices, shifting reimbursement rules, multidisciplinary team approaches and intriguing new treatment options. This evolving environment calls for individual expertise combined with a more complete understanding of the contributions possible from other specialists and non-physician members of the CV Team.

At ACC.18, you’ll have the opportunity to learn everything you need to address the evolving environment and achieve success in your profession. Only by being there can you take full advantage of ACC.18’s world-class educational opportunities, career advice, hands-on training, networking opportunities and more.

On Saturday, March 10, FITs can take part in the popular FIT Forum Mix and Mingle, a special informal, opportunity for FITs to network with cardiology leaders. Can you Stump the Professor? Find out on Sunday, March 11 in this interactive review of cases.

Saturday’s FIT Forum focuses on scholarship and education and the focus on Sunday is what FITs need to know to launch a healthy and successful career. The third annual FIT Jeopardy: Battle of the State Chapters competition will be held on Saturday and Sunday in the Engage@ACC.18 Studio. FITs interested in interventional cardiology will want to make time on Monday to attend the Fellows Bootcamp focused on the topics of interventional basics, structural heart disease management, coronary disease management and peripheral vascular disease.

In addition to these opportunities, early career professionals can learn about the nuts and bolts of starting a niche cardiovascular program and will want to join the Section Highlights for ACC.18 session on Monday. Learn from experts and test your skills in the Case Studies from the Guidelines session (#810). Other sessions of interest focus on payment reform; work-life balance; personalized skills and simulation center; and the Cardiovascular Update for the Clinician Symposia led by Valentin Fuster, MD, PhD, FACC.

CV Team Members

ACC recognizes the importance and value of the CV Team in producing positive patient outcomes. All CV Team members – whether nurses, nurse practitioners, physician assistants, clinical pharmacists, cardiac rehabilitation specialists and other specialist non-physician providers – will find that ACC.18 provides them with amazing opportunities to expand their knowledge, learn about cutting-edge cardiovascular care and research advances, and network and collaborate with peers. In addition to the interdisciplinary cases moderated poster sessions, don’t miss the pharmacology program (#103-105). Other don’t miss sessions include the Shared Decision Making Intensive (#55 and #56); Anticoagulation Challenges in Patients with Dysrhythmias (#729); and Planning Ahead: Palliative Care in End-Stage Heart Failure (#626).

International Members

Cardiology Magazine Image

At ACC.18 in Orlando, attendees will have the opportunity to hear from international cardiovascular disease experts on cardiovascular concerns in other parts of the world and how cardiovascular professionals in other regions cope with those concerns. ACC’s global outreach efforts, including the ACC.18 International Perspectives Sessions, open the door to communications that are invaluable to attendees and their patients.

Twenty international sessions are planned with multiple joint international society programs featured each day. The European Society of Cardiology joins with ACC again for two symposia (#521 and #523), and the 17th Annual Maserio Florio Keynote returns on Sunday, March 11 with Alfred A. Bove, MD, PhD, MACC.

The International Perspectives Sessions features representation from more than 30 international societies. The program pairs countries by topic for cohesive sessions and features a U.S. speaker, a co-chair from the countries’ national societies and a U.S. co-chair.

Begin your global tour on Saturday and take advantage of the many sessions that are offered to meet, network and share information with cardiovascular professionals from around the world. Plus, arrive a day early to attend two special sessions taking place on Friday, March 9. The 10th Annual ACC Cardiovascular Conference on the Middle East will focus on the challenges of diabetes and opportunities to break the chain in the development of heart disease and ischemic cardiomyopathy. And the 6th Annual Conquering Health Care Challenges in the Emerging World offers a look at population health and cardiovascular disease prevention and the role of the government and physician; diseases of modernization in resource-challenged settings; and more.

Intensives

ACC Intensives are designed to target hot and growing areas in cardiovascular practice and use gaps in competencies and knowledge to develop sessions to expand attendees knowledge and understanding.

Innovate or Perish: Emerging Technologies and the Future of Cardiovascular Practice I, II
Saturday, March 10
12:15 - 3:30 p.m.

Emerging technologies and how they are poised to transform cardiovascular practice is the focus of this session, along with real-life examples of innovations in practice and discussion. Join the discussions on the implications of technology on the doctor-patient relationship. A field trip before and after the session is included to the Future Hub in the Expo Hall (#3517) to explore first-hand the technologies shaping the future of cardiology and participate in interactive, thought-provoking presentations.

A General Cardiologist’s Real-World Approach to Adult Congenital Heart Disease: An Interactive Intensive I, II
Sunday, March 11
12:30 – 3:30 p.m.

Learn from a world-renowned faculty about the basics of clinical care including practical diagnostics and hemodynamics; effects of exercise, cath lab diagnostics and therapeutics where applicable; heart failure management; and electrophysiological issues. The interactive, dynamic teaching environment engages participation. Experience adult congenital heart disease through live and digital walks through complex anatomies.

Shared Decision Making for the Clinician: From Buzz to Bedside I, II
Monday, March 12
8:00 a.m. – 12:15 p.m.

Hear from experts about the growing importance of shared decision making and gain a greater understanding of what it is; learn about the evidence base for developing and implementing decision aids; and learn about bringing shared decision making to the mainstream. An ACC Talk, case studies and real world examples of cardiovascular patient decision aids will provide practical resources for incorporating shared decision making and patient decision aids into your daily practice.

Heart 2 Heart Stage

Don’t miss the new and interactive H2H stage sessions with their timely topics affecting clinicians and practice – in the Lounge & Learn Pavilion in Hall C.

How to Navigate ACC.18: An Inside Look at This Year’s Program
March 10, 10:15 – 10:45 a.m.

How to Maintain Your Cardiovascular Certification and Competency
March 10, 11:45 a.m – 12:15 p.m.

MACRAnyms: Understanding the Alphabet Soup
March 11, 9:30 – 10:00 a.m.

Impact of Social Media on Cardiovascular Practice
March 11, 12:00 – 12:30 p.m.

Achieving a Healthy Lifestyle: A Guide for Clinicians and Patients
March 12, 9:30 – 10:00 a.m.

Getting Medications to Your Patients: How Best to Manage Prior Authorizations
March 12, 12:00 – 12:30 p.m.

Lounge & Learn Pavilion

Check out the FIT, Early Career, CV Team, Women in Cardiology, International and Faculty lounges located in the Lounge & Learn Pavilion, Hall C. Look for mini-educational sessions, networking and career advancement opportunities. Don’t miss your chance to meet some of the biggest names in cardiology and learn what the College is doing in your career focus area. Meet up with your colleagues, live stream sessions or participate in informal sessions in the various community lounges. ACC domestic members can also visit the ACC PAC lounge to learn more about the College’s U.S. advocacy efforts. Before you leave, visit the Personalized Skills and Simulation Center.

Stay in the Know

Keep up with the latest scientific research and news from ACC.18 in Orlando. ACC is providing live coverage throughout the meeting, including trial updates, news stories and live video wrap-ups.

Stay in the know by following @ACCinTouch on Twitter and Facebook and use the #ACC18 hashtag. Follow along with daily coverage via the ACC.18 Update e-newsletter or on ACC.org by bookmarking ACC.org/ACC2018.

Don’t miss news from NCDR.18, held from March 7 to 9 in Orlando, by following @ACCCVQuality.

ACC Section Highlights

What does it all mean for your practice? Join an ACC Section Highlights session – new this year – on March 12 from 3:45 – 5:15 p.m. to bring together all the new science and information from ACC.18. Find your session in the ACC.18 app.

ACC.18 Expo: Power Your Mind

ACC.18’s Expo is designed to keep the learning going and circulate new ideas. Interact with nearly 300 companies and organizations to learn about the latest advances in pharmaceuticals, imaging, devices, health IT and the services you need to provide high-quality care for your patients.

Don’t miss the new Future Hub – and the first-ever ACC.18 Innovation Challenge! In this shark tank-like competition, a partnership of ACC and angelMD, entrepreneurs and innovators will pitch their ideas for products and services in digital health and medical devices. Visit the Future Hub to see demonstrations of the latest innovations in digital health, medical devices and educational technology, and to hear ACC Talks and small panel discussions.

More learning destinations can be found in the Industry-Expert Theaters, Innovation Stage, Interactive Learning Labs and Patient Engagement Pavilion.

Make time to visit ACC Central for comprehensive information on its new and ongoing quality campaigns and initiatives, NCDR registries, accreditation services, educational self-assessment programs and more.

Keywords: ACC Publications, Cardiology Magazine, ACC18, ACC Annual Scientific Session, Adult, Education, Medical, Continuing, Education, Pharmacy, Continuing, Clinical Competence, Social Media, Education, Nursing, Continuing, Goals, Patient Participation, Certification, Thinking, Internal Medicine, Decision Making, Faculty, Drug Industry, Students, Volunteers, Heart Diseases


< Back to Listings